Skip to main content

The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

Funding boost to raise access to international clinical trials

Two leading oncology groups will receive $5 million from the Australian Brain Cancer Mission to undertake 5 year programs designed to improve outcomes for children and adults with brain cancer.

The Australian and New Zealand Children’s Haematology Oncology Group (ANZCHOG) and Cooperative Trials Group for Neuro-Oncology (COGNO), will each receive $2.5 million to improve access, and raise participation in international trials.

The funding will enable ANZCHOG to open 5 high quality, international brain cancer clinical trials, with a target of 90% of eligible children with brain cancer enrolling in these trials. COGNO will be funded under the Australian Brain Cancer Mission to expedite start-up of international trials in Australia and increase recruitment by up to 25% in these trials for adults with brain cancer.

For more information: